|| Securities, Unissued Securities
|| Asking Price
|| AUD $2.8M equity capital raise at A$0.90 per share (Pre-offer valuation of A$11.2M)
The Company is a medical device company focused on the development and commercialisation of effective respiratory and airway solutions targeted at the
new born, infants and children neonatal and anaesthetics markets as air leakage in standard resuscitation masks is a critical problem facing midwives
The Company aims to become a global leader in developing and selling the next generation of neonatal resuscitation and ventilation masks that provide effective
sealing without the need for operator intervention techniques to seal, which is currently the practice.
LEARN MORE ABOUT THIS OPPORTUNITY IN A WEBINAR WITH THE CEO RECORDED RECENTLY- VIEW HERE.
Share this Listing